Every-three-week versus dose dense weekly paclitaxel neoadjuvant chemotherapy for advanced stage ovarian, fallopian tube, and peritoneal cancers
- Resource Type
- Abstract
- Source
- In
Gynecologic Oncology November 2014 135(2):383-383 - Subject
- Language
- ISSN
- 0090-8258